Tokyo, Aug. 30 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062703) titled 'Study to evaluate the effect of peeling cosmetics containing phytic acid on skin' on Aug. 30.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Non-randomized Blinding - Single blind -participants are blinded Control - Placebo

Primary Sponsor: Institute - Tsuno Rice Fine Chemicals Co., LTD

Condition: Condition - Healthy adults Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - Verification of the efficacy of a peeling agent containing phytic acid on the skin of healthy men. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - Subjects will apply phytic acid formula to the entire face, then rinse off the product thoroughly and apply a moisturizing gel, once a day for 12 weeks. Interventions/Control_2 - Subjects will apply placebo formula to the entire face, then rinse off the product thoroughly and apply a moisturizing gel, once a day for 12 weeks.

Eligibility: Age-lower limit - 20 years-old

Gender - Male Key inclusion criteria - -Men between the ages of 20 and 60 years old. -Who can be confirmed good health and free from chrocic physical disease by medical interview. -Who not be using any cosmetics with medicinal effects. -Who have been fully informed of the purpose and content of the study, have the ability to consent, and be able to voluntarily agree to participate in the study in writing upon full understanding of the study. -Who be able to come to the laboratory on the designated examination date and be able to undergo the examination. -Who be approved participate in the study by investigator. Key exclusion criteria - -Who are currently undergoing drug treatment for some disease. -Who have serious skin diseases such as dermatitis. -Who cannot intentionally refrain from being exposed to direct sunlight during the study period, for example, by sunbathing. -Who show statistical outliers in measurements related to the primary and secondary outcomes of the study. Who with allergies (to pharmaceuticals or products related to test materials). -Who have a current or past habit of continuous ingestion or application of drugs claiming to improve the skin. -Who use cosmetics that have a strong effect on the skin (the investigator will determine) -Who are deemed inappropriate for this study by the investigator. Target Size - 30

Recruitment Status: Recruitment status - Completed Date of protocol fixation - 2023 Year 03 Month 31 Day Date of IRB - 2023 Year 04 Month 06 Day Anticipated trial start date - 2023 Year 04 Month 07 Day Last follow-up date - 2023 Year 08 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057814

Disclaimer: Curated by HT Syndication.